Ayasreh Fierro Nadia, Miquel Rodríguez Rosa, Matamala Gastón Ana, Ars Criach Elisabet, Torra Balcells Roser
Enfermedades Renales Hereditarias, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma de Barcelona, REDINREN, ISCIII, Barcelona, España.
Servicio de Nefrología, Hospital Universitario de Canarias, REDINREN, ISCIII, Tenerife, España.
Nefrologia. 2017 May-Jun;37(3):235-243. doi: 10.1016/j.nefro.2016.10.024.
In recent years there has been a reclassification of hereditary tubulointerstitial renal diseases. The old concepts of nephronoptisis or medullary cystic disease have been reordered based on the discovery of new genes. The 2015 KDIGO guidelines proposed a unification of terminology, diagnostic criteria and monitoring. So far 4genes causing autosomal dominant tubulointerstitial kidney disease have been described: MUC1, UMOD, HNF1B and REN. Although the mutation in each of them causes distinctive features in how they present, all have in common the progressive tubulointerstitial damage and renal fibrosis. In this article, we present a review of the guidelines and the literature, and some practical recommendations for dealing with this disease.
近年来,遗传性肾小管间质性肾病已重新分类。基于新基因的发现,肾单位萎缩或髓质囊性疾病的旧概念已被重新梳理。2015年KDIGO指南提出了术语、诊断标准和监测的统一。到目前为止,已描述了4种导致常染色体显性遗传性肾小管间质性肾病的基因:MUC1、UMOD、HNF1B和REN。尽管它们各自的突变在临床表现上具有独特特征,但所有这些基因都有进行性肾小管间质损伤和肾纤维化的共同特点。在本文中,我们对指南和文献进行了综述,并提出了一些应对该疾病的实用建议。